<DOC>
	<DOC>NCT00536237</DOC>
	<brief_summary>Part A: This study will determine that MK0524 is well tolerated and does not effect lipids and blood glucose when given alone. Part B: Determine dose ranges for MK0524 and MK0524 plus Niaspan(R) on the effects of lipids and blood glucose.</brief_summary>
	<brief_title>MK0524A Phase IIb Study (0524A-011)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Flushing</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Men and women, 18 to 70 years of age for whom treatment with Niacin would be appropriate but who are not taking &gt; 50mg at screening Must be willing to complete electronic diary Subject is having menopausal hot flashes and/or receiving hormone replacement therapy (HRT) You have a history of cancer, gout, peptic ulcers, diabetes, liver, heart disease or high blood pressure or you are HIV positive You consume more than 14 alcoholic drinks per week or more than 2 drinks per day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>